Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Booster Immunization of Inactivated Omicron COVID-19 Vaccine
NCT05381350Phase 3Completed
- Sponsor
- Sinovac Biotech Ltd.
- Start
- Jun 2022
- Primary completion
- Sep 2022
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of inactivated COVID-19 vaccine (Omicron variant) in coronavirus disease 2019 (COVID-19), sponsored by Sinovac Biotech Ltd.. Started Jun 2022; status: completed.
02
Drugs
inactivated COVID-19 vaccine (Omicron variant)
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05381350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05381350.